Remote ischemic preconditioning protects against liver ischemia-reperfusion injury via heme oxygenase-1-induced autophagy. 2014

Yun Wang, and Jian Shen, and Xuanxuan Xiong, and Yonghua Xu, and Hai Zhang, and Changjun Huang, and Yuan Tian, and Chengyu Jiao, and Xuehao Wang, and Xiangcheng Li
Department of Oncological Surgery 2, Xuzhou City Central Hospital, The Affiliated Hospital of the Southeast University Medical School (Xuzhou), The Tumor Research Institute of the Southeast University (Xuzhou), Xuzhou, Jiangsu Province, China.

BACKGROUND Growing evidence has linked autophagy to a protective role of preconditioning in liver ischemia/reperfusion (IR). Heme oxygenase-1 (HO-1) is essential in limiting inflammation and preventing the apoptotic response to IR. We previously demonstrated that HO-1 is up-regulated in liver graft after remote ischemic preconditioning (RIPC). The aim of this study was to confirm that RIPC protects against IR via HO-1-mediated autophagy. METHODS RIPC was performed with regional ischemia of limbs before liver ischemia, and HO-1 activity was inhibited pre-operation. Autophagy was assessed by the expression of light chain 3-II (LC3-II). The HO-1/extracellular signal-related kinase (ERK)/p38/mitogen-activated protein kinase (MAPK) pathway was detected in an autophagy model and mineral oil-induced IR in vitro. RESULTS In liver IR, the expression of LC3-II peaked 12-24 h after IR, and the ultrastructure revealed abundant autophagosomes in hepatocytes after IR. Autophagy was inhibited when HO-1 was inactivated, which we believe resulted in the aggravation of liver IR injury (IRI) in vivo. Hemin-induced autophagy also protected rat hepatocytes from IRI in vitro, which was abrogated by HO-1 siRNA. Phosphorylation of p38-MAPK and ERK1/2 was up-regulated in hemin-pretreated liver cells and down-regulated after treatment with HO-1 siRNA. CONCLUSIONS RIPC may protect the liver from IRI by induction of HO-1/p38-MAPK-dependent autophagy.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008297 Male Males
D011524 Protoporphyrins Porphyrins with four methyl, two vinyl, and two propionic acid side chains attached to the pyrrole rings. Protoporphyrin IX occurs in hemoglobin, myoglobin, and most of the cytochromes.
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001343 Autophagy The segregation and degradation of various cytoplasmic constituents via engulfment by MULTIVESICULAR BODIES; VACUOLES; or AUTOPHAGOSOMES and their digestion by LYSOSOMES. It plays an important role in BIOLOGICAL METAMORPHOSIS and in the removal of bone by OSTEOCLASTS. Defective autophagy is associated with various diseases, including NEURODEGENERATIVE DISEASES and cancer. Autophagocytosis,ER-Phagy,Lipophagy,Nucleophagy,Reticulophagy,Ribophagy,Autophagy, Cellular,Cellular Autophagy,ER Phagy
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D015427 Reperfusion Injury Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA. Ischemia-Reperfusion Injury,Injury, Ischemia-Reperfusion,Injury, Reperfusion,Reperfusion Damage,Damage, Reperfusion,Injury, Ischemia Reperfusion,Ischemia Reperfusion Injury,Ischemia-Reperfusion Injuries,Reperfusion Damages,Reperfusion Injuries

Related Publications

Yun Wang, and Jian Shen, and Xuanxuan Xiong, and Yonghua Xu, and Hai Zhang, and Changjun Huang, and Yuan Tian, and Chengyu Jiao, and Xuehao Wang, and Xiangcheng Li
December 2014, Critical care medicine,
Yun Wang, and Jian Shen, and Xuanxuan Xiong, and Yonghua Xu, and Hai Zhang, and Changjun Huang, and Yuan Tian, and Chengyu Jiao, and Xuehao Wang, and Xiangcheng Li
November 2016, Oncotarget,
Yun Wang, and Jian Shen, and Xuanxuan Xiong, and Yonghua Xu, and Hai Zhang, and Changjun Huang, and Yuan Tian, and Chengyu Jiao, and Xuehao Wang, and Xiangcheng Li
March 2008, Transplantation,
Yun Wang, and Jian Shen, and Xuanxuan Xiong, and Yonghua Xu, and Hai Zhang, and Changjun Huang, and Yuan Tian, and Chengyu Jiao, and Xuehao Wang, and Xiangcheng Li
January 2023, Frontiers in medicine,
Yun Wang, and Jian Shen, and Xuanxuan Xiong, and Yonghua Xu, and Hai Zhang, and Changjun Huang, and Yuan Tian, and Chengyu Jiao, and Xuehao Wang, and Xiangcheng Li
March 2015, World journal of gastroenterology,
Yun Wang, and Jian Shen, and Xuanxuan Xiong, and Yonghua Xu, and Hai Zhang, and Changjun Huang, and Yuan Tian, and Chengyu Jiao, and Xuehao Wang, and Xiangcheng Li
June 2010, Transplantation proceedings,
Yun Wang, and Jian Shen, and Xuanxuan Xiong, and Yonghua Xu, and Hai Zhang, and Changjun Huang, and Yuan Tian, and Chengyu Jiao, and Xuehao Wang, and Xiangcheng Li
May 2004, The Journal of surgical research,
Yun Wang, and Jian Shen, and Xuanxuan Xiong, and Yonghua Xu, and Hai Zhang, and Changjun Huang, and Yuan Tian, and Chengyu Jiao, and Xuehao Wang, and Xiangcheng Li
April 2012, Journal of gastroenterology and hepatology,
Yun Wang, and Jian Shen, and Xuanxuan Xiong, and Yonghua Xu, and Hai Zhang, and Changjun Huang, and Yuan Tian, and Chengyu Jiao, and Xuehao Wang, and Xiangcheng Li
May 2018, Life sciences,
Yun Wang, and Jian Shen, and Xuanxuan Xiong, and Yonghua Xu, and Hai Zhang, and Changjun Huang, and Yuan Tian, and Chengyu Jiao, and Xuehao Wang, and Xiangcheng Li
March 2014, The Journal of surgical research,
Copied contents to your clipboard!